Prof. Kristy K. Brock is currently a Professor with tenure in the Department of Imaging Physics at the University of Texas MD Anderson Cancer Center, where she is the Director for the Image-Guided Cancer Therapy Research Program. Her research has focused on image guided cancer therapy, where she has developed a biomechanical model-based deformable image registration algorithm to integrate imaging into treatment planning, delivery, and response assessment as well as to understand and validate imaging signals through correlative pathology. Her algorithm was licensed and incorporated into a commercial treatment planning system. She is board certified by the American Board of Radiology in Therapeutic Medical Physics and holds a joint appointment with the Department of Radiation Physics at MD Anderson. Dr. Brock has published over 150 papers in peer-reviewed journals, is the Editor of the book'Image Processing in Radiation Therapy' and has been the PI/co-PI on over 25 peer-reviewed, industry, and institutional grants.

A genome is the body's instruction manual. It's made of DNA and there is a copy in almost every cell. Through genome sequencing and genomics, clinicians can better understand how cancer cells might evolve and what treatments will be most responsive, known as precision and personalised medicine. Furthermore, genomics combined with technologies such as machine-learning and artificial intelligence (AI) has huge, as yet untapped, potential for determining a healthy person's future risk of cancer. To sequence the first genome cost $3 billion and took 13 years.